Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management

G Rogler, A Singh, A Kavanaugh, DT Rubin - Gastroenterology, 2021 - Elsevier
Inflammatory bowel diseases (IBDs) are systemic diseases that manifest not only in the gut
and gastrointestinal tract, but also in the extraintestinal organs in many patients. The quality …

Therapeutic effect of baicalin on inflammatory bowel disease: A review

X Wang, L Xie, J Long, K Liu, J Lu, Y Liang… - Journal of …, 2022 - Elsevier
Ethnopharmacological relevance Baicalin (BI) is an important biologically active flavonoid
isolated from the root of Scutellaria radix (Huang Qin). Traditionally Scutellaria radix was the …

A meta-analysis on sleep quality in inflammatory bowel disease

A Ballesio, A Zagaria, F Baccini, F Micheli… - Sleep Medicine …, 2021 - Elsevier
Evidence of poor sleep quality in inflammatory bowel disease (IBD, ie, Crohn's disease and
ulcerative colitis) has been reported but never systematically reviewed or meta-analysed …

[HTML][HTML] Inflammatory bowel disease prevalence: surveillance data from the US National Health and Nutrition Examination Survey

MH Weisman, O Stens, HS Kim, JK Hou… - Preventive Medicine …, 2023 - Elsevier
Determining the overall US prevalence of Inflammatory Bowel Disease (IBD) is essential to
national level prevention programs and population risk assessment; however currently US …

[HTML][HTML] Pivotal Role of Intestinal Microbiota and Intraluminal Metabolites for the Maintenance of Gut–Bone Physiology

N Grüner, AL Ortlepp, J Mattner - International Journal of Molecular …, 2023 - mdpi.com
Intestinal microbiota, and their mutual interactions with host tissues, are pivotal for the
maintenance of organ physiology. Indeed, intraluminal signals influence adjacent and even …

[HTML][HTML] Paradoxical reactions to biologicals in chronic inflammatory systemic diseases

I Kremenevski, O Sander, M Sticherling… - Deutsches Ärzteblatt …, 2022 - ncbi.nlm.nih.gov
Background Biological agents that contain substances affecting the immune system are
increasingly being used to treat chronic inflammatory systemic diseases. Aside from the …

[HTML][HTML] Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation

S Weissman, P Sinh, TI Mehta, RK Thaker… - World journal of …, 2020 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) causes systemic vascular inflammation. The increased
risk of venous as well as arterial thromboembolic phenomena in IBD is well established …

The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients: a real-life multicentre cohort study

C De Galan, M Truyens, H Peeters… - Journal of Crohn's …, 2022 - academic.oup.com
Abstract Background and Aims Extra-intestinal manifestations are frequently reported in
inflammatory bowel diseases. However, data comparing the effect of vedolizumab and …

Extraintestinal manifestation of inflammatory bowel disease in Asian patients: a multinational study

SK Park, Z Wong, SH Park, K Van Vu, KB Bang… - Digestive and Liver …, 2021 - Elsevier
Background/aim Although inflammatory bowel disease (IBD) incidence has increased over
the past two decades in Asia, data on extraintestinal manifestations (EIMs) of IBD in Asian …

[HTML][HTML] Predicting diagnostic biomarkers associated with immune infiltration in Crohn's disease based on machine learning and bioinformatics

W Bao, L Wang, X Liu, M Li - European Journal of Medical Research, 2023 - Springer
Objective The objective of this study is to investigate potential biomarkers of Crohn's disease
(CD) and the pathological importance of infiltration of associated immune cells in disease …